immunotherapy
| 4 min read
New cancer immunotherapy shows promise in treating cancer
| 2 min read
Kiromic’s GMP manufacturing facility in Houston will support the company’s first-in-human allogenic CAR-T trial
| 3 min read
Researchers have published on a new CAR-T cell therapy using CXCR5
| 3 min read
Codiak demonstrates potential of engineered exosomes to stimulate targeted, antitumor immunity
| 3 min read
The companies will collaborate on an allogeneic cell therapy candidate for solid tumor cancers
| 3 min read
Nutrient-based safety switches can be applied to CAR-T, stem cell and TCR therapies
| 2 min read
Expression data suggest potential of PVRIG inhibition to enhance T cell priming and infiltration into both inflamed and less inflamed tumors
| 1 min read
Although antibody-based immunotherapies have greatly facilitated precision medicine in cancer, the increasingly smaller patient populations and challenging manufacture make them an expensive proposition. This webinar will highlight new approaches for accelerating antibody discovery and optimization.
